Is Arcadia Biosciences, Inc. (RKDA) Halal?
Shariah Screening — 5 Standards
Based on financial data from December 2024
| Standard | Debt Ratio | Cash Ratio | Receivables | Income | Status |
|---|---|---|---|---|---|
| AAOIFI | 3.6% / 30% | 98.7% / 30% | 71.4% / 30% | 15.5% / 5% | ✗ NOT HALAL |
| DJIM | 3.6% / 33% | 98.7% / 33% | 71.4% / 33% | 15.5% / 5% | ✗ NOT HALAL |
| MSCI | 1.1% / 33% | 31.4% / 33% | 22.7% / 33% | 15.5% / 5% | ✗ NOT HALAL |
| S&P | 3.6% / 33% | 98.7% / 33% | 71.4% / 33% | 15.5% / 5% | ✗ NOT HALAL |
| FTSE | 1.1% / 33% | 31.4% / 33% | 22.7% / 50% | 15.5% / 5% | ✗ NOT HALAL |
Financial Highlights
Profitability
| Gross Margin | 40.4% | |
| Operating Margin | -88.5% | |
| Net Margin | -98.0% | |
| Return on Equity (ROE) | -64.6% | |
| Return on Assets (ROA) | -31.5% |
Cash Flow & Balance Sheet
| Operating Cash Flow | -$10M |
| Free Cash Flow | -$10M |
| Total Debt | $155,000 |
| Current Ratio | 3.7 |
| Total Assets | $14M |
Price & Trading
| Last Close | $1.52 |
| 50-Day MA | $1.91 |
| 200-Day MA | $3.37 |
| Avg Volume | 37K |
| Beta | 0.6 |
|
52-Week Range
$1.46
| |
About Arcadia Biosciences, Inc. (RKDA)
Arcadia Biosciences, Inc. produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring. The company was incorporated in 2002 and is headquartered in Dallas, Texas.
Related Halal Stocks in Consumer Defensive
Frequently Asked Questions
Is Arcadia Biosciences, Inc. (RKDA) halal to invest in?
Based on our screening using AAOIFI Standard 21 (the strictest methodology), Arcadia Biosciences, Inc. is Not Halal. The company fails one or more screening criteria. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.
What is Arcadia Biosciences, Inc.'s debt ratio?
Arcadia Biosciences, Inc.'s debt ratio is 3.6% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 1.1%.
What are Arcadia Biosciences, Inc.'s key financial metrics?
Arcadia Biosciences, Inc. has a market capitalization of $3M, and revenue of $5M. The company maintains a gross margin of 40.4% and a net margin of -98.0%. Return on equity stands at -64.6%.
How often is the screening data updated?
Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.
Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.